LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat

Brain Research

Volumn 1253, Issue , 2009, Pages 184-190

  Belayev, Ludmila ^a   Khoutorova, Larissa ^a   Atkins, Kristal ^a   Cherqui, Alice ^b   Alvarez Builla, Julio ^c   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Behavioral; Histopathology; LAU 0901; Middle cerebral artery occlusion; Neuroprotection; PAF antagonist

Indexed keywords

2,4,6 TRIMETHYL 1, 4 DIHYDRO PYRIDINE 3, 5 DICARBOXYLIC ACID; 2,4,6 TRIMETHYL 1,4 DIHYDRO 3,5 PYRIDINEDICARBOXYLIC ACID 2 (3,4 DICHLOROPHENOXY)ETHYL BIS(MORPHOLINOMETHYL)METHYL ESTER; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ANIMALS; BRAIN; CELL COUNT; DIHYDROPYRIDINES; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

ANIMALIA; RATTUS; RODENTIA;

EID: 58249144068     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.074     Document Type: Article

References (24)

1. Aspey B.S., Alp M.S., Patel Y., and Harrison M.J. Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischemia - an initial screening study. Metab. Brain Dis. 12 (1997) 237-249
2. Bazan N.G. COX-2 as a multifunctional neuronal modulator. Nat. Med. 7 (2001) 414-415
3. Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J. Lipid Res. 44 (2003) 2221-2233
4. Bazan N.G. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32 (2005) 89-103
5. Bazan N.G., and Allan G. Platelet-activating factor and other bioactive lipids. In: Ginsberg M.D., and Bogousslavsky J. (Eds). Cerebrovascular Disease, Pathophysiology, Diagnosis and Management (1998), Blackwell Science Publishers, Malden, Massachusetts 532-555
6. Bazan N.G., Sunkel C., Marcheselli V.L., and Builla G.J. Assignee Louisiana State University, 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs. US Patent 6,566,359 (2003) B1
7. Belayev L., Alonso O.F., Busto R., Zhao W., and Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. neurological and pathological evaluation of an improved model. Stroke 27 (1996) 1616-1622
8. Belayev L., Khoutorova L., Atkins K., Gordon W.C., Alvarez-Builla J., and Bazan N.G. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp. Neurol. 214 (2008) 253-258
9. Boetkjaer A., Boedker M., Cui J.G., Zhao Y., and Lukiw W.J. Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells. Neurosci. Lett. 426 (2007) 59-63
10. Bozlu G., Atici A., Turhan A.H., Polat A., Nayci A., Okuyaz C., and Taskinlar H. Platelet-activating factor antagonist (ABT-491) decreases neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Brain Res. 1143 (2007) 193-198
11. Carnevale N.T. Integration of data obtained at fixed intervals. Brain Res. Bull. 16 (1986) 137-142
12. Clark G.D., Happel L.T., Zorumski C.F., and Bazan N.G. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9 (1992) 1211-1216
13. Cortina M.S., Gordon W.C., Lukiw W.J., and Bazan N.G. Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria. Exp. Eye Res. 81 (2005) 742-750
14. Dietrich W.D., Dewanjee S., Prado R., Watson B.D., and Dewanjee M.K. Transient platelet accumulation in the rat brain after common carotid artery thrombosis. An 111 In-labeled platelet study. Stroke 24 (1993) 1534-1540
15. Eddleston M., and Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 54 (1993) 15-36
16. Ginsberg M.D., and Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29 (1998) 529-534
17. He J., and Bazan H.E. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Invest. Ophthalmol. Vis. Sci. 47 (2006) 883-891
18. Izquierdo I., Fin C., Schmitz P.K., Da Silva R.C., Jerusalinsky D., Quillfeldt J.A., Ferreira M.B., Medina J.H., and Bazan N.G. Memory enhancement by intrahippocampal, intraamygdala, or intraentorhinal infusion of platelet-activating factor measured in an inhibitory avoidance task. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5047-5051
19. Kato K., Clark G.D., Bazan N.G., and Zorumski C.F. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367 (1994) 175-179
20. Kimelberg, H.K., Norenberg, M.D., 1989. Astrocytes. Sci. Am. 260, 66-72, 74, 76.
21. Kokubo Y., Matson G.B., Liu J., Mancuso A., Kayama T., Sharp F.R., and Weinstein P.R. Correlation between changes in apparent diffusion coefficient and induction of heat shock protein, cell-specific injury marker expression, and protein synthesis reduction on diffusion-weighted magnetic resonance images after temporary focal cerebral ischemia in rats. J. Neurosurg. 96 (2002) 1084-1093
22. Konig J.F.R., and Klippel R.A. The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem (1963), Lippincott Williams and Wilkins, Baltimore
23. Tian X., and Bazan N.G. Neuroprotection by platelet-activating factor antagonism. Ann. N. Y. Acad. Sci. 1053 (2005) 455-456
24. Tower D.B. A century of neuronal and neuroglial interactions, and their pathological implications: an overview. Prog. Brain Res. 94 (1992) 3-17